MichelleHladunewich CanadaSunnybrook Health Sciences Centre

MichelleHladunewich
Dr. Hladunewich completed her Doctor of Medicine at the University of Alberta, her internal medicine training at the University of Toronto and then proceeded to complete her Critical Care and Nephrology Fellowships at Stanford University Medical Center. In addition to her research training in glomerular physiology, she completed a Master’s of Science in Clinical Investigation at Stanford University. Dr. Hladunewich joined the University of Toronto in 2003, and was promoted to Associate Professor in 2013 and to Full Professor in 2019. She is the Clinical Trials Director at the Toronto Glomerulonephritis Clinic and Registry. She is the medical lead for the Kidney Disease and Pregnancy Clinic (PreKid Clinic), and the Physician in Chief of Medicine at Sunnybrook Health Sciences Centre. Her research program includes studies in glomerular-based disease as well as pregnancy related kidney disease. Dr. Hladunewich is currently the Ontario Renal Network Medical Lead for Glomerulonephritis and Specialty Clinics.
Upload Picture
https://storage.unitedwebnetwork.com/files/1099/e50f620e7b76b3c8e0b90af56d2c918b.jpg
First Name
Michelle
Last Name
Hladunewich
Institution
Country.
Canada

Thursday, February 6, 2025

Time Session
1 p.m.
2:30 p.m.
SS3
MichelleHladunewich Chair CanadaSunnybrook Health Sciences Centre
ShilpanjaliJesudason Chair AustraliaRoyal Adelaide Hospital and University of Adelaide, Australia
  • Welcome and Background on Obstetric Nephrology Evolution
    SS3-001
    MichelleHladunewich Speaker CanadaSunnybrook Health Sciences Centre
  • Overview of the TT Program and Toolkit Launch
    SS3-002
    ShilpanjaliJesudason Speaker AustraliaRoyal Adelaide Hospital and University of Adelaide, Australia
  • Trainer Perspective
    SS3-003
    GhadaAnkawi Speaker Saudi ArabiaKing Abdulaziz University
  • Trainer Perspective
    SS3-004
    DIVYABAJPAI Speaker IndiaProfessor, Department of Nephrology, Seth G.S.M.C. and K.E.M. Hospital, Mumbai, India
  • Panel Discussion, Questions and Group Discussion
    SS3-005
Mogra Hall A 404